About us Get involved Research COVAX Marketplace News & stories Careers Contact Governance CEPI is a Norwegian Association. The primary governing body is the Board, which has 12 voting members (four investors and eight independent members representing competencies including industry, global health, science, resource mobilisation, finance) and five observers. All investors are invited to join our Investors Council, which nominates Investor representatives to the Board and has some rights including approval any single investments over $100 m. Two additional bodies support and guide CEPI’s work: the Scientific Advisory Committee is the principal scientific advisory group to the Board and Secretariat and the Joint Coordination Group works with critical external stakeholders to advance CEPI’s portfolio of vaccines. Key documents related to CEPI's activities, policies, and governance can be accessed below. Filter by category: All Filter by year: All Documents 139 View: 10 25 50 Proposal to establish a globally fair allocation system Equitable Access 2020 Download PDF 210 KBbytes Upload 7 Sep 2021 Board 24-25 June 2021 Meeting Summary Board Meeting Summaries 2021 Download PDF 157 KBbytes Upload 19 Aug 2021 Board Audit and Risk Committee 1 Mar 2021 Meeting Summary Board Meeting Summaries 2021 Download PDF 90 KBbytes Upload 13 Aug 2021 Board Audit and Risk Committee 19 Nov 2020 Meeting Summary Board Meeting Summaries 2020 Download PDF 73 KBbytes Upload 13 Aug 2021 CEPI’s slavery and human trafficking statement: 2021 CEPI Policies 2021 Download PDF 118 KBbytes Upload 3 Aug 2021 CEPI 15-17 March 2021 Board Meeting Summary Board Meeting Summaries 2021 Download PDF 198 KBbytes Upload 28 Jul 2021 Press Release - CEPI Enable study expands to more countries in West Africa (French) Download PDF 136 KBbytes Upload 28 Jul 2021 JCG Meeting 23 Feb 2021 Summary Joint Coordination Group 2021 Download PDF 146 KBbytes Upload 17 May 2021 COVAX Manufacturing Task Force Equitable Access 2021 Download PDF 785 KBbytes Upload 14 May 2021 CEPI mid-term review and COVID-19 response review: Combined Report Strategy & Progress 2021 Download PDF 7 MBbytes Upload 4 May 2021 1 2 3 4 5 6 7 8 9 10 11 12 13 14 ABOUT US Why we exist Mission Approach Who we are Overview Leadership Board Investors & Partners Scientific Advisory Committee Joint Coordination Group Antiracism statement Anti-Slavery Statement Governance Articles of association Board Meeting Summaries Board of Directors' report, annual accounts and Auditor's statement Business Plan CEPI Policies Equitable Access Financial Internal policies Investors Council Joint Coordination Group Members Meetings Other Guidance for Awardees Scientific Advisory Committee Strategy & Progress Terms of reference GET INVOLVED Support CEPI Invest in CEPI Progress Work with CEPI Work at CEPI Follow our work Calls for Proposals RESEARCH & DEVELOPMENT Our portfolio Platform Technology Priority diseases MERS Lassa Nipah Disease X Rift Valley fever Chikungunya Ebola Vaccine science Biological Standards, Assays & Animal Models Collect vaccine data Researching emerging infectious diseases INFO & ACTION News & stories Outbreaks Careers Contact Social LinkedIn Twitter Legal Terms of use Privacy policy Procurement tenders Reporting Concern ©2021 CEPI. All rights reserved